Lombard Odier Asset Management (Switzerland)’s Intellia Therapeutics NTLA Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio NTLA Stock Details NTLA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$2.96M	Buy
2022 Q4	$2.13M	Hold
2022 Q3	$3.41M	Sell
2022 Q2	$3.38M	Sell
2022 Q1	$5.75M	Sell
2021 Q4	$13.4M	Sell
2021 Q3	$20M	Sell
2021 Q2	$25.1M	Sell
2021 Q1	$22.7M	Buy